Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics
Vancouver, Canada, June 24, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind' or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced earlier this month it has engaged a prominent government and political affairs consulting and lobbying firm to support its mission of advancing psychedelic-based treatments.
As psychedelics gain traction in the pharmaceutical industry for their potential to treat conditions such as Post-Traumatic Stress Disorder (PTSD) and other mental health disorders, Clearmind recognizes the importance of navigating complex regulatory landscapes and fostering greater acceptance among policymakers in the U.S.. The company's partnered with the esteemed firm to support the integration of psychedelic therapies into mainstream healthcare by advocating for informed, science-based regulatory frameworks.
'We are pleased to collaborate with a team of seasoned government affairs experts to help shape the future of psychedelic medicine,' said Dr. Adi Zuloff-Shani, Chief Executive Officer of Clearmind Medicine. 'Psychedelics hold immense promise for transforming mental health treatment, but their novelty requires proactive engagement with regulators and policymakers to ensure safe and equitable access. This partnership underscores our commitment to driving progress in this rapidly evolving field.'
The consulting firm, known for its expertise in navigating federal and state regulatory environments, will work closely with Clearmind to educate policymakers on the therapeutic potential of psychedelics, support the development of balanced regulations, and foster strategic alliances to advance the company's innovative pipeline, including its lead candidate, CMND-100, currently in Phase I/IIa clinical trials for AUD at prestigious institutions like Yale School of Medicine and Johns Hopkins University.
About Clearmind Medicine Inc.
Clearmind is a clinical-stage psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements.
The Company's intellectual portfolio currently consists of nineteen patent families including 31 granted patents. The Company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
Shares of Clearmind are listed for trading on Nasdaq under the symbol 'CMND' and the Frankfurt Stock Exchange under the symbol 'CWY0.'
For further information visit: https://www.clearmindmedicine.com or contact:
Investor Relationsinvest@clearmindmedicine.com
Telephone: (604) 260-1566US: CMND@crescendo-ir.com
General InquiriesInfo@Clearmindmedicine.comwww.Clearmindmedicine.com
Forward-Looking Statements:
This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act and other securities laws. Words such as 'expects,' 'anticipates,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates' and similar expressions or variations of such words are intended to identify forward-looking statements. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time with the Securities and Exchange Commission ('SEC'), including, but not limited to, the risks detailed in the Company's annual report on Form 20-F for the fiscal year ended October 31, 2024 and subsequent filings with the SEC. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Clearmind is not responsible for the contents of third-party websites.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Is Tesla Stock a Millionaire Maker?
In the past 15 years, this top EV stock has climbed more than 20,000%. Tesla shares have always sold for a premium, which is detached from the reality of the current business. Investors considering buying the stock must believe the company will make good on its plans for autonomous driving and robotics. These 10 stocks could mint the next wave of millionaires › Looking back at its history as a public company, Tesla (NASDAQ: TSLA) has generated serious wealth for investors. The auto industry disruptor has seen its shares skyrocket 20,290% since its initial public offering in June 2010 (as of June 25). Had you invested just $5,000 back then, there would be a $1 million balance in your portfolio right now. No one would argue with that kind of impressive past gain. But will the leading EV stock be a millionaire maker in the future? Tesla might be the most closely watched business in the world, partly, because of how it disrupted the global car market. Investors also keep tabs on what CEO Elon Musk is doing, as well as his plans for the company (more on this below). However, investors shouldn't lose sight of what Tesla really is today, which is a challenged company that sells innovative and tech-enhanced EVs. In the first quarter, the business reported $14 billion of automotive revenue, 72% of the total. Total revenue was up just 0.9% in 2024, then it declined 9.2% in Q1 2025. Operating income in the first quarter tanked 66%, thanks to lower average selling prices, fewer deliveries, and higher expenses. To be fair, this is an extremely inventive company that's working at the cutting edge of exciting technologies. But someone viewing Tesla with a clear lens would see that this is a struggling business. Its core operations are under pressure, without a doubt. What valuation should Tesla trade at knowing the reality of the business today? Even with a more reasonable price-to-earnings ratio (P/E) of 50 (compared to its current P/E ratio of 179), which is what luxury automaker Ferrari trades for, the stock has 72% downside. That certainly doesn't give investors any reason to be bullish. Based on the current market cap of $1 trillion and P/E ratio of 179, Tesla is wildly overvalued. But the story stock has seemingly always traded at a steep valuation, as investors continue to bet on a future that sees the company realizing its potential as a dominant force in autonomous driving and robotics. The company has finally launched a robotaxi service in Austin, Texas. This was highly anticipated and something that Musk has talked about for years. However, I think it turned out to be a big nothing burger. There were no Cybercabs. Less than two dozen Model Ys were used instead. There were human supervisors in all the vehicles. And videos of the robotaxis in action showed numerous issues, spurring an investigation by the National Highway Traffic Safety Administration. At the same time, Alphabet's Waymo is handling 250,000 trips per week in multiple cities. And an application is in place to start testing the service in New York City. Tesla appears to still have a long way to go. The company is also leveraging its AI capabilities to work on Optimus, a humanoid robot. Musk believes it will produce 1 million units annually by the end of this decade. Besides placing these machines in its factories, the goal is to sell them to other companies. If all goes according to plan, which is a very uncertain outcome, then Tesla could make its investors into millionaires down the road. The end markets for robotaxis and humanoid robots are estimated to be measured in the trillions of dollars. The company's ability to not only have these technologies achieve mass adoption, but to also capture a sizable chunk of the opportunity, could create a financial windfall. However, I think there's also a good chance that the business won't deliver up to its heightened expectations, a perspective that's supported by a history of constant delays. This is a stock that I'm still avoiding. Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $409,114!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $38,173!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $713,547!* Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of June 23, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet and Tesla. The Motley Fool has a disclosure policy. Is Tesla Stock a Millionaire Maker? was originally published by The Motley Fool
Yahoo
an hour ago
- Yahoo
Where Will Nvidia Be in the Next 3 Years?
Nvidia's full-stack platform made it a primary beneficiary in the ongoing AI revolution. Blackwell chips are seeing demand far outpacing supply. Although the valuation is expensive, Nvidia can soar even higher from the current levels in the coming three years. 10 stocks we like better than Nvidia › Rewind to early 2023 -- few believed that Nvidia (NASDAQ: NVDA) could climb any higher. It already felt expensive and fully priced. Then it surged nearly tenfold, reshaping itself from a chip supplier into a global artificial intelligence (AI) infrastructure behemoth. Today, with a market cap of $3.5 trillion, it's not about whether Nvidia dominates the AI landscape, it's about what's next. In its most recent quarter (the first quarter of fiscal 2026, ended April 27), Nvidia delivered a jaw-dropping $44.1 billion in revenue, up 69% year over year. For perspective, that's more than Starbucks and Netflix earn combined in a quarter. Of that total, $39.1 billion came from the data center segment, representing a 73% increase year over year. These results reflect the dramatic demand for the company's AI infrastructure from enterprises and governments. Several major growth drivers remain intact. Enterprises and cloud providers are investing aggressively in data centers and AI infrastructure. The AI data center market is expected to be worth nearly $100 billion by 2030. The company's Blackwell architecture chips, the successors to the widely adopted Hopper chips, are already seeing strong demand from hyperscalers and enterprises, primarily for AI inference workloads (deploying AI models in a production environment) -- far ahead of supply. To cater to the demand, Nvidia reserved full production capacity at Wistron's new Taiwan plant through 2026 for Blackwell and Rubin AI servers. Nvidia is no longer just a chipmaker. It now offers a full-stack solution to accelerated computing needs. From hardware to software and networking, Nvidia's ecosystem supports high-performance and low-latency deployment. Nvidia's software offerings are contributing recurring and high-margin revenue streams. Hence, as software becomes a larger portion of the company's overall revenue mix, gross margin can increase from the already high 61%. Beyond data centers, Nvidia is also positioned to benefit from the increasing demand for AI technologies across new use cases in areas such as automotive, edge AI, robotics, and industrial design. These use cases are still developing but can prove significant catalysts in the long run. Despite its many pros, Nvidia has its share of risks. Nvidia is facing revenue headwinds due to restrictions on international exports, especially to China. The company estimated a loss in H20 chip revenue of around $8 billion in the second quarter due to U.S. export controls for China. In the event of escalating geopolitical tensions, this poses a significant risk to Nvidia. Competition is also heating up. Advanced Micro Devices is catching up, while hyperscalers such as Alphabet and Amazon are also developing custom chips. Analysts now estimate the stock's 12-month price target around $176, with the highest target estimate of $250 and the lowest of $100. To see if these estimates make sense, let's use consensus analyst estimates for Nvidia's earnings per share (EPS). Analysts are estimating Nvidia's EPS to be $4.32, $5.72, and $6.44 in fiscal 2026, fiscal 2027, and fiscal 2028, respectively. Nvidia is trading at 36 times forward earnings. Applying a more conservative multiple of 30x, (down from today's elevated levels but suitable for a high-growth technology stock), and you get a three-year price target of around $193 -- roughly 25% upside from today's levels, or around 7% compound annual growth rate (CAGR). This does not seem a very attractive proposition in the current high-inflation environment. However, if Nvidia's bull case holds, then the company's EPS can reach $7.63 in fiscal 2028 and enjoy a premium multiple of 35x (more in line with current levels). In that case, the company's share price can be nearly $267 at the end of 2028 -- around 73% up from today's level, or a 20% CAGR. Finally, in the bear case, Nvidia's EPS is estimated to be around $5.11 and forward P/E multiple can be close to 25 (the lower end for a high-growth company), translating into a $127.11 share price. This would be almost 17% lower than today's price. Nvidia's valuation already incorporates a significant amount of optimism, and the base case, with 7% annual returns, may not adequately justify the risk in a high-interest rate environment. While there is upside potential, the stock currently makes sense primarily for long-term investors with a high risk appetite who are very optimistic about the AI infrastructure opportunity. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Manali Pradhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Amazon, Netflix, Nvidia, and Starbucks. The Motley Fool has a disclosure policy. Where Will Nvidia Be in the Next 3 Years? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
2 Artificial Intelligence (AI) Stocks That Could Be Poised for a Big Second-Half Comeback
Growth stocks, including AI players, faced challenging times earlier in the first half as investors worried about the economy. The following two players could benefit from positive news in the months to come. 10 stocks we like better than Apple › The first half of the year has been somewhat of a rollercoaster ride for stocks -- and investors. Though all three major indexes have now crossed into positive territory, that wasn't the story just a few weeks ago. The S&P 500 index, the Dow Jones Industrial Average, and the Nasdaq Composite each sank in the early months of the year amid concerns that President Donald Trump's import tariff plan would hurt the economy, earnings, and stock performance. Since then, positive signs, such as initial trade deals and strong earnings reports, have eased investors' minds, and as a result, the indexes rebounded. Still, certain growth stocks, such as some artificial intelligence (AI) players, remain in the doldrums and are heading for a first-half decline. Let's take a look at two that could be poised for a big second-half comeback. As Trump announced his tariff plan, investors worried about what it could mean for Apple (NASDAQ: AAPL), in particular, because the company produces most of its iPhones in China, a country most highly targeted by tariffs. Though the president exempted electronics products, this exemption is temporary. He even threatened Apple recently with a 25% tariff on all imported iPhones. Apple made a move to diversify its manufacturing base, promising that most U.S.-destined iPhones would soon be made in India, but that country faces tariffs, too. All this tariff uncertainty weighed on Apple stock, pushing it down by about 20% so far this year. So, why should we expect a comeback in the second half? While Trump is serious about bringing manufacturing back to the U.S., it's unlikely that he and his administration would make moves to destroy some of the country's top companies, including Apple. We've seen signs of flexibility in initial U.S. trade deals with the U.K. and China, so it's reasonable to expect a compromise with tech companies that won't limit their growth. Meanwhile, Apple is a well-established player with a strong financial situation. The company has more than $48 billion in cash and marketable securities. So, it has the resources to address challenges. At the same time, the smartphone giant has a newish growth engine in the form of services. Services revenue, thanks to Apple's huge base of installed devices, has reached record levels quarter after quarter. This growth should continue as loyal Apple users continue to rely on the company for data storage, digital entertainment, and more. All this means that today, Apple looks like a bargain, trading at 27 times forward earnings estimates, down from more than 35 times late last year. These levels offer it plenty of room to run, and it may do just that on any good news in the second half. SoundHound AI (NASDAQ: SOUN) is a specialist in voice AI, with its technology powering voice systems in cars and restaurant ordering systems, to mention just two examples. The stock has plummeted 50% so far this year, but I see this as more of a buying opportunity than a reason to worry, and here's why. First, after a 150% increase in SoundHound shares over the past year, it's not surprising that some investors may have locked in gains in recent times. Second, growth companies -- particularly young growth companies -- may struggle to expand during rough economic times, so investors' concerns earlier this year led to a sell-off of these sorts of players. Today, it's important to look at SoundHound's earnings performance and long-term prospects. The company is in high-growth mode, with revenue soaring 150% in the latest quarter as it expands its customer base across various sectors. This is key because use across industries lowers risk, meaning if one customer or industry suffers, SoundHound won't necessarily suffer alongside it. SoundHound has numerous patents protecting its technology, a system that immediately translates speech into meaning without the speech-to-text step. This results in speed and improved quality. SoundHound's rapid growth and revenue of $29 million in the quarter, along with the forecasted $140 billion AI voice market size, suggest that much more growth could be ahead for this voice specialist. All this means that as uncertainty about the general economy lifts and SoundHound continues to deliver growth, the stock could roar higher in the second half of the year. Before you buy stock in Apple, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Apple wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $713,547!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $966,931!* Now, it's worth noting Stock Advisor's total average return is 1,062% — a market-crushing outperformance compared to 177% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Adria Cimino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple. The Motley Fool has a disclosure policy. 2 Artificial Intelligence (AI) Stocks That Could Be Poised for a Big Second-Half Comeback was originally published by The Motley Fool Sign in to access your portfolio
